Gary Patou, Chief Medical Officer at Pacira Pharmaceuticals, Inc. (PCRX), sold 20,000 shares at $100.26 ($2.0M) on 2014-08-07, disclosed to the SEC on 2014-08-08.
Scheduled sale ($2.0M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| XENE | SELL | 2023-12-15 | $624K | — | Filing → |
| XENE | SELL | 2023-12-15 | $1.0M | — | Filing → |
| XENE | SELL | 2022-11-28 | $276K | — | Filing → |